Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
The Journal of Biological Chemistry
|
February 9, 1996
Structure of a G-protein-coupling domain of a muscarinic receptor predicted by random saturation mutagenesis
D Hill-Eubanks, E S Burstein, T A Spalding, et al.
Journal of Neurochemistry
|
February 1, 1997
Interactions of muscarinic receptors with the heterotrimeric G proteins Gq and G12: transduction of proliferative signals
E S Burstein, H Bräuner-Osborne, T A Spalding, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1995
Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis
T A Spalding, E S Burstein, H Brauner-Osborne, et al.
The Journal of Biological Chemistry
|
August 15, 1998
Identification of a ligand-dependent switch within a muscarinic receptor
T A Spalding, E S Burstein, S C Henderson, et al.
Neuropharmacology
|
June 19, 2002
Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H(3) receptor
P Wellendorph, M W Goodman, E S Burstein, et al.
Journal of Clinical Pharmacology
|
March 1, 1988
Triazolam kinetics: interaction with cimetidine, propranolol, and the combination
H Friedman, D J Greenblatt, E S Burstein, et al.
Oncogene
|
October 30, 1998
The ras-related GTPase rac1 regulates a proliferative pathway selectively utilized by G-protein coupled receptors
E S Burstein, D J Hesterberg, J S Gutkind, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1987
Bromazepam pharmacokinetics: influence of age, gender, oral contraceptives, cimetidine, and propranolol
H R Ochs, D J Greenblatt, H Friedman, et al.
Clinical Pharmacokinetics
|
May 1, 1989
Clearance of the antihistamine doxylamine. Reduced in elderly men but not in elderly women
H Friedman, D J Greenblatt, J M Scavone, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 4, 2007
In vitro pharmacology of clinically used central nervous system-active drugs as inverse H(1) receptor agonists
R A Bakker, M W Nicholas, T T Smith, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
The Journal of Biological Chemistry
|
February 9, 1996
Structure of a G-protein-coupling domain of a muscarinic receptor predicted by random saturation mutagenesis
D Hill-Eubanks, E S Burstein, T A Spalding, et al.
Journal of Neurochemistry
|
February 1, 1997
Interactions of muscarinic receptors with the heterotrimeric G proteins Gq and G12: transduction of proliferative signals
E S Burstein, H Bräuner-Osborne, T A Spalding, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
December 1, 1995
Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis
T A Spalding, E S Burstein, H Brauner-Osborne, et al.
The Journal of Biological Chemistry
|
August 15, 1998
Identification of a ligand-dependent switch within a muscarinic receptor
T A Spalding, E S Burstein, S C Henderson, et al.
Neuropharmacology
|
June 19, 2002
Molecular cloning and pharmacology of functionally distinct isoforms of the human histamine H(3) receptor
P Wellendorph, M W Goodman, E S Burstein, et al.
Journal of Clinical Pharmacology
|
March 1, 1988
Triazolam kinetics: interaction with cimetidine, propranolol, and the combination
H Friedman, D J Greenblatt, E S Burstein, et al.
Oncogene
|
October 30, 1998
The ras-related GTPase rac1 regulates a proliferative pathway selectively utilized by G-protein coupled receptors
E S Burstein, D J Hesterberg, J S Gutkind, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1987
Bromazepam pharmacokinetics: influence of age, gender, oral contraceptives, cimetidine, and propranolol
H R Ochs, D J Greenblatt, H Friedman, et al.
Clinical Pharmacokinetics
|
May 1, 1989
Clearance of the antihistamine doxylamine. Reduced in elderly men but not in elderly women
H Friedman, D J Greenblatt, J M Scavone, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 4, 2007
In vitro pharmacology of clinically used central nervous system-active drugs as inverse H(1) receptor agonists
R A Bakker, M W Nicholas, T T Smith, et al.
Page
of 4